In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection

Human Immunology

Volumn 73, Issue 8, 2012, Pages 783-787

  O'Connor, Geraldine M ^a   Seich Al Basatena, Nafisa Katrin ^b   Olavarria, Viviana ^c   MacNamara, Aidan ^b   Vine, Alison ^b   Ying, Qi ^d   Hisada, Michie ^e   Galvão Castro, Bernardo ^f   Asquith, Becca ^b   McVicar, Daniel W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d SAIC FREDERICK INC   (United States)

^e TAKEDA PHARMACEUTICALS   (United States)

^f INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IMMUNOGLOBULIN RECEPTOR; KILLER IMMUNOGLOBULIN RECEPTOR 3DS1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BRAZIL; CHILD; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAMAICA; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TROPICAL SPASTIC PARAPARESIS; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BRAZIL; CHILD; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAMAICA; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PREVALENCE; PROGNOSIS; RECEPTORS, KIR3DS1; SPINAL CORD DISEASES; VIRAL LOAD;

EID: 84864071494     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.05.006     Document Type: Article

References (33)

1. Hlela C., Shepperd S., Khumalo N.P., Taylor G.P. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 2009, 11:205-214.
2. Watanabe T. Current status of HTLV-1 infection. Int J Hematol 2011, 94:430-434.
3. Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
4. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
5. Manns A., Hisada M., La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999, 353:1951-1958.
6. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 4:586-593.
7. Bangham C.R., Osame M. Cellular immune response to HTLV-1. Oncogene 2005, 24:6035-6046.
8. Jeffery K.J., Siddiqui A.A., Bunce M., Lloyd A.L., Vine A.M., Witkover A.D., et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000, 165:7278-7284.
9. Macnamara A., Rowan A., Hilburn S., Kadolsky U., Fujiwara H., Suemori K., et al. HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 2010, 6:e1001117.
10. Gardiner C.M. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet 2008, 35:1-8.
11. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin Immunol 2008, 20:311-316.
12. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 31:429-434.
13. + NK cells during acute human immunodeficiency virus type 1 infection. J Virol 2009, 83:6798-6805.
14. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007, 204:3027-3036.
15. O'Connor G.M., Guinan K.J., Cunningham R.T., Middleton D., Parham P., Gardiner C.M. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 2007, 178:235-241.
16. Carr W.H., Rosen D.B., Arase H., Nixon D.F., Michaelsson J., Lanier L.L. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 2007, 178:647-651.
17. + T cell epitopes. AIDS Res Hum Retroviruses 2007, 23:451-455.
18. Goedert J.J., Li H.C., Gao X.J., Chatterjee N., Sonoda S., Biggar R.J., et al. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007, 121:1092-1097.
19. Galvao-Castro B., Loures L., Rodriques L.G., Sereno A., Ferreira Junior O.C., Franco L.G., et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 1997, 37:242-243.
20. Dourado I., Alcantara L.C., Barreto M.L., da Gloria Teixeira M., Galvao-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 2003, 34:527-531.
21. De Castro-Costa C.M., Araujo A.Q., Barreto M.M., Takayanagui O.M., Sohler M.P., da Silva E.L., et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 2006, 22:931-935.
22. Jeffery K.J., Usuku K., Hall S.E., Matsumoto W., Taylor G.P., Procter J., et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999, 96:3848-3853.
23. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner WA, editor. Human, retrovirology. New York: Raven Press; 1990. p. 191-7.
24. John Hansen E. Joint report: 13th IHWS, Section A5: Sequence based HLA typing. In: Proceedings of the 13th international histocompatibility workshop and conference, vol. 1. Seattle, Washington; 2002. p. 304-416.
25. Kulkarni S., Martin M.P., Carrington M. KIR genotyping by multiplex PCR-SSP. Methods Mol Biol 2010, 612:365-375.
26. Dehee A., Cesaire R., Desire N., Lezin A., Bourdonne O., Bera O., et al. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 2002, 102:37-51.
27. Anderson M., Green P.L. Growth and manipulation of a human T-cell leukemia virus type 2 full-length molecular clone. Methods Mol Biol 2005, 304:409-421.
28. Anderson M.D., Ye J., Xie L., Green P.L. Transformation studies with a human T-cell leukemia virus type 1 molecular clone. J Virol Methods 2004, 116:195-202.
29. Coulthart M.B., Posada D., Crandall K.A., Dekaban G.A. On the phylogenetic placement of human T cell leukemia virus type 1 sequences associated with an Andean mummy. Infect Genet Evol 2006, 6:91-96.
30. Li H.C., Fujiyoshi T., Lou H., Yashiki S., Sonoda S., Cartier L., et al. The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an Andean mummy. Nat Med 1999, 5:1428-1432.
31. Norman P.J., Abi-Rached L., Gendzekhadze K., Korbel D., Gleimer M., Rowley D., et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 2007, 39:1092-1099.
32. Talledo M., Lopez G., Huyghe J.R., Verdonck K., Gonzalez E., Clark D., et al. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru. Hum Immunol 2010, 71:804-808.
33. Matsuura E., Yamano Y., Jacobson S. Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol 2010, 5:310-325.